Bacterial translocation during graft-versus-host disease after small bowel transplantation is reduced following inhibition of inducible nitric oxide synthesis

Transplantation

Volumn 69, Issue 11, 2000, Pages 2415-2421

  Langrehr, Jan M ^a   Machens, Christine ^a   Zill, Edith ^a   Leder, Korinna ^a   Nüssler, Andreas ^a   Hoffman, Rosemary ^b   Neuhaus, Peter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIUM CULTURE; BLOOD CULTURE; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; INTESTINE GRAFT; LIVER; MESENTERY LYMPH NODE; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; RAT; SPLEEN;

EID: 0034659828     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200006150-00035     Document Type: Article

References (39)

1. Grant D. 1997 report of the international intestinal transplant registry. Transplantation 1999; 67: 1061.
2. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 87.
3. Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169: 1543.
4. Adams LB, Hibbs JB Jr, Taintor RR, Krahenbuhl JL. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol 1990; 144: 2725.
5. Hoffman RA, Langrehr JM, Billiar TR, Curran RD, Simmons RL. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol 1990; 145: 2220.
6. Nathan CF. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051.
7. Langrehr JM, Murase N, Markus PM, et al. Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest 1992; 90: 679.
8. Langrehr JM, Hoffman RA, Lancaster JR Jr, Simmons RL. Nitric oxide: a new endogenous immunomodulator. Transplantation 1993; 55: 1205.
9. Jamieson NV, Joysey V, Friend PJ, et al. Graft-versus-host disease in solid organ transplantation. Transpl Int 1991; 4: 67.
10. Roberts JP, Ascher NL, Lake J, et al. Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology 1991; 14: 274.
11. Goulet O, Brousse N, Revillon Y, Ricour C. Pathology of human intestinal transplantation. In: Grant D, Wood RFM, eds. Small bowel transplantation. London, UK: Edward Arnold, 1994: 112.
12. Grant D, Zhong R, Gunn H, et al. Graft-versus-host disease associated with intestinal transplantation in the rat: host immune function and general histology. Transplantation 1989; 48: 545.
13. Saat RE, DeBruin RWF, Heineman E, Jeekel J, Marquet RL. The limited efficacy of cyclosporine in preventing rejection and graft-versus-host disease in orthotopic small bowel transplantation in rats. Transplantation 1990; 50: 374.
14. Todo S, Reyes J, Furukawa H, et al. Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995; 222: 270.
15. Ferrara JLM, Cooke KR, Pan L, Krenger W. The immunopathophysiology of acute graft-versus-host disease. Stem Cells 1996; 14: 473.
16. Hoffman RA, Nüssler NC, Gleixner SL, et al. Attenuation of lethal graft-versus-host disease by inhibition of nitric oxide synthase. Transplantation 1997; 63: 94.
17. Schraut WH, Lee KKW, Dawson PJ, Hurst RD. Graft-versus-host disease induced by small bowel allografts: clinical course and pathology. Transplantation 1986; 41: 286.
18. Langrehr JM, Hoffman RA, Banner B, et al. Induction of graft-versus-host disease and rejection by sensitized small bowel allografts. Transplantation 1991; 52: 399.
19. Langrehr JM, Markus PM, Banner B, Lee KKW, Schraut WH. Induction of chronic graft-versus-host disease in a rat model after transplantation of sensitized small bowel allografts. Am J Surg 1994; 167: 579.
20. Deitch EA. Bacterial translocation of the gut flora: proceedings of NIH conference on advance in understanding trauma and burn injury. J Trauma 1990; 30 (suppl): S184.
21. Fändrich F, Schröder J, Exner B, et al. Correlation between graft-versus-host induced immunosuppression and host natural killer cell activity in small bowel transplantation. World J Surg 1996; 20: 1041.
22. Abreu-Martin M, Targan SR. Regulation of immune responses of the intestinal mucosa. Crit Rev Immunol 1996; 16: 277.
23. Kirkman R, Lear PA, Madara JL, Tilney NL. Small intestine transplantation in the rat: immunology and function. Surgery 1984; 96: 280.
24. Lee KKW Schraut WH. In vitro allograft irradiation prevents graft-versus-host disease in small bowel transplantation. J Surg Res 1985; 38: 364.
25. Delta E, Ulrichs K, Schack T, et al. Graft-versus-host reactions in small bowel transplantation and possibilities for its circumvention. Am J Surg 1986; 151: 379.
26. Shaffer D, Maki T, Demichele SJ, et al. Studies in small bowel transplantation: prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum. Transplantation 1988; 45: 262.
27. Smith GJ, Ingham-Clark CL, Crane PW, Lear PA, Wood RFM Fabre JW. Ex vivo perfusion of intestinal allografts with anti-T cell monoclonal antibody/ricin A chain conjugates for the suppression of graft-versus-host disease. Transplantation 1992; 53: 717.
28. Langrehr JM, Müller AR, Bergonia HA, et al. Detection of nitric oxide by EPR-spectroscopy during rejection and GVHD after small-bowel transplantation. Surgery 1992; 112: 395.
29. Hoffman RA, Langrehr JM, Berry LM, et al. Bystander injury of host lymphoid tissue during murine graft-versus-host disease is mediated by nitric oxide. Transplantation 1996; 61: 610.
30. Misko TP, Moore WM, Kasten TP, et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993; 233: 119.
31. Worrall NK, Lazenby WD, Misko TP, et al. Modulation of in-vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995; 81: 63.
32. Worrall NK, Boasquevisque CH, Botney MD, et al. Inhibition of inducible nitric oxide synthase ameliorates functional and histological changes of acute lung allograft rejection. Transplantation 1997; 63: 1095.
33. Mattsson P, Zeevi A, Cai J, et al. Effect of aminoguanidine and cyclosporine on lung allograft rejection. Ann Thorac Surg 1996; 62: 207.
34. Corbett JA, Tilton RG, Chang K, et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1991; 41: 552.
35. Browne BJ, Johnson CP, Roza AM, Adams MB. Endotoxemia after small bowel transplantation. Transplant Proc 1992; 24: 1107.
36. Price BA, Cumberland NS, Ingham-Clark CL, Pockley AG, Lear PA, Wood RFM. The effect of rejection and graft-versus-host disease on small intestinal microflora and bacterial translocation after rat small bowel transplantation. Transplantation 1993; 56: 1072.
37. Sorrells DL, Friend C, Koltuksuz U, et al. Inhibition of nitric oxide with aminoguanidine reduces bacterial translocation after endotoxin challenge in vivo. Arch Surg 1996; 131: 1155.
38. Unno N, Wang H, Menconi MJ, et al. Inhibition of inducible nitric oxide synthase ameliurates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997; 113: 1246.
39. BBe intestinal epithelial monolayers. Am J Physiol 1995; 268: G361.